A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

NCT03623529 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Catecholamine-resistant Hypotension (CRH)
Distributive Shock
High Output Shock
Septic Shock

Interventions

DRUG: LJPC-501 (angiotensin II)
DRUG: Placebo

Sponsor

La Jolla Pharmaceutical Company